SL
Scott L Burrows sold $2.3M of SYRE stock
Scott L Burrows, Chief Financial Officer of Spyre Therapeutics, Inc. (SYRE), sold 25,000 shares of SYRE stock worth $2.3M, per an SEC Form 4 filed Oct 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 30, 2026, 3 days before it was made public.
SYRE has moved +15.6% since the trade date, from $89.03 to $102.91 (Nov 12, 2026 close).
- Traded
- Sep 30, 2026
- Disclosed
- Oct 3, 2026
- Filing delay
- 3 days
- Price since
- +15.6%
- Role
- Chief Financial Officer
- Source
- SEC Form 4